MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹5,078 Cr | ₹25 Cr | ₹23 Cr | ₹49 Cr | ₹57 Cr |
What is the latest Secured Loans ratio of MANKIND PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹5,078 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹57 Cr |
How is Secured Loans of MANKIND PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,078 Cr | 20,317.49 | |
| Mar2024 | ₹25 Cr | 7.44 | |
| Mar2023 | ₹23 Cr | -52.71 | |
| Mar2022 | ₹49 Cr | -14.76 | |
| Mar2021 | ₹57 Cr | - | |
Compare Secured Loans of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹95,330.0 Cr | -3.1% | -3.3% | -8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -3.1% |
-3.3% |
-8.6% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses